|By PR Newswire||
|December 1, 2016 09:45 AM EST|
ATLANTA, Dec. 1, 2016 /PRNewswire/ -- Specimatch, the first continual clinical trial monitoring service, announced today the availability of its web-based software service for cancer patients and oncologists. On Specimatch.com, users can easily and intuitively connect to clinical trials personally matched to the patient's genetic and clinical profiles.
Reducing the impact of cancer continues to grow as a priority across not only the healthcare sector, but also influential institutions ranging from global advocacy groups to the White House. Clinical trials are a key driver in bringing cancer breakthroughs to market, yet 75 percent of investigators fail to enroll the targeted amount of patients per trial despite hundreds of millions of dollars in spending per trial. Although trials offer first access to cutting-edge precision treatments, approximately 85 percent of U.S. cancer patients lack access to these opportunities and only 3 percent are successfully placed into trials.
"Accessibility to cancer trials is not only critical to improving the quality of precision medicine, but it is also an invaluable option for the cancer patient whose survival is at stake," said Dr. Ken Dixon, founder of Specimatch, and founder/surgical oncologist of Surgical Oncologists of Northeast Georgia. "We created Specimatch as a solution for patients and oncologists to tap into a complex landscape of breakthrough treatments with both accuracy and simplicity. Specimatch alleviates the gaps in care by putting the power of precision medicine in the hands of patients and the doctors with whom they partner in the fight against cancer."
Specimatch is a monthly subscription-based software service offering:
- Continual 24/7 Monitoring – Combs database (powered by Thomson Reuters) of more than 250,000 trials to identify matching trials in real time, based on a user-completed clinical and genetic profile
- Email Notifications – Alerts users to latest clinical trials matching their specific molecular diagnosis
- Patient Interface – Allows patients to manage their information and matching trials anywhere through the intuitive, web- and mobile-friendly Care Timeline
- Care Provider Interface – Allows clinicians to review and manage information for each of their patients in one place
- HIPAA-Compliant Cloud Infrastructure – Protects patient information with best-in-class measures exceeding HIPAA requirements
"Specimatch restores the power that a cancer diagnosis can often steal from a patient," Dr. Dixon said. "We are proud to provide this timely information and access because we believe it's how cancer will meet its match and survival rates will improve."
For more information on Specimatch, visit www.specimatch.com.
Specimatch is a first-of-its-kind web-based software service enabling patients and their doctors to intelligently share an expanded knowledge base to better determine the right individual cancer care. Headquartered in Atlanta, Ga., Specimatch was founded in 2016 by Dr. Ken Dixon, founder/surgical oncologist of Surgical Oncologists of Northeast Georgia, and is designed, operated and managed by a team of experienced clinical oncologists and proprietary software developers. For more information, visit www.specimatch.com and follow updates from Specimatch on Facebook and Twitter.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/specimatch-launches-first-of-its-kind-clinical-trial-monitoring-for-cancer-patients-300371405.html
Dec. 10, 2016 04:30 PM EST Reads: 1,891
Dec. 10, 2016 04:30 PM EST Reads: 1,330
Dec. 10, 2016 04:30 PM EST Reads: 1,804
Dec. 10, 2016 03:45 PM EST Reads: 883
Dec. 10, 2016 03:45 PM EST Reads: 1,306
Dec. 10, 2016 03:30 PM EST Reads: 897
Dec. 10, 2016 02:45 PM EST Reads: 1,235
Dec. 10, 2016 02:45 PM EST Reads: 895
Dec. 10, 2016 02:30 PM EST Reads: 2,048
Dec. 10, 2016 01:45 PM EST Reads: 704
Dec. 10, 2016 01:00 PM EST Reads: 400
Dec. 10, 2016 01:00 PM EST Reads: 1,246
With major technology companies and startups seriously embracing IoT strategies, now is the perfect time to attend @ThingsExpo 2016 in New York. Learn what is going on, contribute to the discussions, and ensure that your enterprise is as "IoT-Ready" as it can be! Internet of @ThingsExpo, taking place June 6-8, 2017, at the Javits Center in New York City, New York, is co-located with 20th Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry p...
Dec. 10, 2016 12:45 PM EST Reads: 2,138
@DevOpsSummit at Cloud taking place June 6-8, 2017, at Javits Center, New York City, is co-located with the 20th International Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to wait for long developm...
Dec. 10, 2016 12:30 PM EST Reads: 1,968
In his keynote at 18th Cloud Expo, Andrew Keys, Co-Founder of ConsenSys Enterprise, provided an overview of the evolution of the Internet and the Database and the future of their combination – the Blockchain. Andrew Keys is Co-Founder of ConsenSys Enterprise. He comes to ConsenSys Enterprise with capital markets, technology and entrepreneurial experience. Previously, he worked for UBS investment bank in equities analysis. Later, he was responsible for the creation and distribution of life sett...
Dec. 10, 2016 12:15 PM EST Reads: 7,477